Terms: = Endocrine gland cancer AND BUB1B, BUBR1, 701, ENSG00000156970, SSK1, BUB1beta, MAD3L, hBUBR1, Bub1A, O60566 AND Treatment
52 results:
1. Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma.
Li F; Si W; Xia L; Yin D; Wei T; Tao M; Cui X; Yang J; Hong T; Wei R
Mol Cancer; 2024 May; 23(1):90. PubMed ID: 38711083
[TBL] [Abstract] [Full Text] [Related]
2. Comprehensively analyzing the genetic alterations, and identifying key genes in ovarian cancer.
Tang Q; Atiq W; Mahnoor S; Abdel-Maksoud MA; Aufy M; Yaz H; Zhu J
Oncol Res; 2023; 31(2):141-156. PubMed ID: 37304238
[TBL] [Abstract] [Full Text] [Related]
3. [Analysis of risk factors for recurrence of differentiated thyroid carcinoma after surgical resection combined with iodine-131 and TSH suppression therapy].
Ye T; Lai S; Cao B; Xu B; Wang R
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 May; 37(5):370-374. PubMed ID: 37138400
[No Abstract] [Full Text] [Related]
4. A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib.
Guo M; Shu Y; Chen G; Li J; Li F
Sci Rep; 2022 Nov; 12(1):20601. PubMed ID: 36446798
[TBL] [Abstract] [Full Text] [Related]
5. Impact of hemolysis on multi-OMIC pancreatic biomarker discovery to derisk biomarker development in precision medicine studies.
Searfoss R; Shah P; Ofori-Mensa K; Bussberg V; Tolstikov V; Greenwood B; Li H; Richardson K; Miller GM; DeCicco C; Granger E; Rodrigues LO; Grund EM; Moser AJ; Sarangarajan R; Narain NR; Kiebish MA
Sci Rep; 2022 Jan; 12(1):1186. PubMed ID: 35075163
[TBL] [Abstract] [Full Text] [Related]
6. Adjuvant Radiotherapy in Patients With Pancreatic Adenocarcinoma. Is It Still Appealing in Clinical Trials? A Meta-analysis and Review of the Literature.
Pasqualetti F; Sainato A; Morganti R; Laliscia C; Vasile E; Gonnelli A; Montrone S; Gadducci G; Giannini N; Coccia N; Fuentes T; Zanotti S; Falconi M; Paiar F
Anticancer Res; 2021 Oct; 41(10):4697-4704. PubMed ID: 34593417
[TBL] [Abstract] [Full Text] [Related]
7. Nomograms for Individualized Evaluation of Prognosis in Adrenocortical Carcinomas for the Elderly: A Population-Based Analysis.
Wang W; Chang G; Sun Y; Zhuo R; Li H; Hu Y; Ye C
J Invest Surg; 2022 May; 35(5):1153-1160. PubMed ID: 34433351
[TBL] [Abstract] [Full Text] [Related]
8. Nomogram prediction for the involution of the ablation zone after radiofrequency ablation treatment in patients with low-risk papillary thyroid carcinoma.
He H; Zhang Y; Song Q; Zhao J; Li W; Li Y; Luo Y
Int J Hyperthermia; 2021; 38(1):1133-1139. PubMed ID: 34348562
[TBL] [Abstract] [Full Text] [Related]
9. Incidence and risk of venous thromboembolism according to primary treatment in women with ovarian cancer: A retrospective cohort study.
Yuk JS; Lee B; Kim K; Kim MH; Seo YS; Hwang SO; Yoon SH; Kim YB
PLoS One; 2021; 16(4):e0250723. PubMed ID: 33909674
[TBL] [Abstract] [Full Text] [Related]
10. Frailty based on the memorial Sloan Kettering Frailty Index is associated with surgical decision making, clinical trial participation, and overall survival among older women with ovarian cancer.
Filippova OT; Tin AL; Alonso J; Vickers AJ; Tew WP; Gardner GJ; Sonoda Y; Roche KL; Zivanovic O; Chi DS; Shahrokni A
Gynecol Oncol; 2021 Jun; 161(3):687-692. PubMed ID: 33773807
[TBL] [Abstract] [Full Text] [Related]
11. Utilizing an interim futility analysis of the OVAL study (VB-111-701/GOG 3018) for potential reduction of risk: A phase III, double blind, randomized controlled trial of ofranergene obadenovec (VB-111) and weekly paclitaxel in patients with platinum resistant ovarian cancer.
Arend RC; Monk BJ; Herzog TJ; Moore KN; Shapira-Frommer R; Ledermann JA; Tewari KS; Secord AA; Rachmilewitz Minei T; Freedman LS; Miller A; Shmueli SF; Lavi M; Penson RT
Gynecol Oncol; 2021 May; 161(2):496-501. PubMed ID: 33637348
[TBL] [Abstract] [Full Text] [Related]
12. Favorable outcomes of papillary thyroid microcarcinoma concurrent with Graves' disease after radioactive iodine therapy.
Nishihara E; Ito Y; Kudo T; Ito M; Fukata S; Nishikawa M; Akamizu T; Miyauchi A
Endocr J; 2021 Jun; 68(6):649-654. PubMed ID: 33551434
[TBL] [Abstract] [Full Text] [Related]
13. Lutetium oxodotreotide (
Smith-Palmer J; Leeuwenkamp OR; Virk J; Reed N
BMC Cancer; 2021 Jan; 21(1):10. PubMed ID: 33402120
[TBL] [Abstract] [Full Text] [Related]
14. Limited resection vs. pancreaticoduodenectomy for primary duodenal adenocarcinoma: a systematic review and meta-analysis.
Burasakarn P; Higuchi R; Nunobe S; Kanaji S; Eguchi H; Okada KI; Fujii T; Nagakawa Y; Kanetaka K; Yamashita H; Yamada S; Kuroda S; Aoyama T; Akahori T; Nakagawa K; Yamamoto M; Yamaue H; Sho M; Kodera Y;
Int J Clin Oncol; 2021 Mar; 26(3):450-460. PubMed ID: 33386555
[TBL] [Abstract] [Full Text] [Related]
15. Statin use and survival following a diagnosis of ovarian cancer: A prospective observational study.
Majidi A; Na R; Jordan SJ; De Fazio A; Webb PM;
Int J Cancer; 2021 Apr; 148(7):1608-1615. PubMed ID: 33034053
[TBL] [Abstract] [Full Text] [Related]
16. Comparison of FOLFIRINOX and Gemcitabine Plus Nab-paclitaxel for treatment of Metastatic Pancreatic cancer: Using Korean Pancreatic cancer (K-PaC) Registry.
Lee JC; Woo SM; Shin DW; Kim J; Yang SY; Kim MJ; Kim JW; Kim JW; Lee WJ; Cha HS; Park P; Kim J; Hwang JH
Am J Clin Oncol; 2020 Sep; 43(9):654-659. PubMed ID: 32889836
[TBL] [Abstract] [Full Text] [Related]
17. Identification of new candidate genes and signalling pathways associated with the development of neuroendocrine pancreatic tumours based on next generation sequencing data.
Kit OI; Trifanov VS; Petrusenko NA; Gvaldin DY; Kutilin DS; Timoshkina NN
Mol Biol Rep; 2020 Jun; 47(6):4233-4243. PubMed ID: 32451928
[TBL] [Abstract] [Full Text] [Related]
18. Estimates of Overall Survival in Patients With cancer Receiving Different treatment Regimens: Emulating Hypothetical Target Trials in the Surveillance, Epidemiology, and End Results (SEER)-Medicare Linked Database.
Petito LC; García-Albéniz X; Logan RW; Howlader N; Mariotto AB; Dahabreh IJ; Hernán MA
JAMA Netw Open; 2020 Mar; 3(3):e200452. PubMed ID: 32134464
[TBL] [Abstract] [Full Text] [Related]
19. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract] [Full Text] [Related]
20. Effects of metastasectomy and other factors on survival of patients with ovarian metastases from gastric cancer: a systematic review and meta-analysis.
Zhang C; Hou W; Huang J; Yin S; Wang P; Zhang Z; Tan Y; Xu H
J Cell Biochem; 2019 Sep; 120(9):14486-14498. PubMed ID: 31050365
[TBL] [Abstract] [Full Text] [Related]
[Next]